CH
抗体药类似物
Research Grade Girentuximab
All
  • CatalogTD-HS840016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsWX-G250,cG250,CAS:916138-87-9
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Girentuximab


Catalog No. TD-HS840016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Membrane antigen MN, P54/58N, Carbonic anhydrase 9, Renal cell carcinoma-associated antigen G250, CA-IX, CAIX, pMW1, Carbonic anhydrase IX, RCC-associated antigen G250, Carbonate dehydratase IX, CA9, MN, G250
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q16790
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names WX-G250,cG250,CAS:916138-87-9
Background Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).
Note For research use only. Not for use in clinical or therapeutic applications.